Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

A new study will investigate whether SGLT-2 inhibitor Farxiga can delay the progression of heart failure in people with and without type 2 diabetes
First drug trial to show delay in type 1 diagnoses, heart and kidney benefits from Trulicity in type 2, huge focus on time-in-range, positive results for both Tandem’s...
A new online resource for people with type 2 diabetes offers a place to share stories, get connected, and learn tips for day-to-day management – BeyondType2.org
An inside look into former Aetna CEO Mark Bertolini's book, "Mission Driven Leadership: My Journey as a Radical Capitalist"
AgaMatrix blood glucose meters and strips by Amazon could make ordering diabetes supplies more convenient and cheaper
The latest updates on time-in-range goals for people with all types of diabetes, and insights linking FreeStyle Libre scanning frequency to outcomes.
Resource at DANAtech.org for AADE members with current diabetes device information, news, education, and app reviews; supported by the Helmsley Charitable Trust
FDA updates Invokana label – the type 2 diabetes therapy now improves heart health in type 2’s with established heart disease in addition to glucose lowering
Big focus on heart health outcome trials with PIONEER 6 and CAROLINA in the spotlight; plus promising CGM data in adolescents with type 1 diabetes
To commemorate World Obesity Day, we are raising attention on terribly stigmatizing language around obesity and weight
MiniMed 780G to add automated correction boluses and Bluetooth, aims to launch by April 2020; Guardian Connect users can now use IQcast on Apple iPhones
A new guidance document from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) calls for more patient-centered care and...
The latest on the first automated insulin delivery system with automatic boluses and no-fingersticks CGM. The pivotal trial has been temporarily paused and will resume...
Recently announced results from the REWIND and EMPRISE studies show heart protective effects of GLP1-agonist Trulicity and SGLT-2 inhibitor Jardiance in people with and...
Sanofi covers all insulins under this program, including Toujeo, Lantus, Admelog, Apidra.
By Peter Rentzepis and Kelly Close Passing of Dr. Lois Jovanovic, the leading figure in pregnancy and diabetes, brings sorrow to many; friends and colleagues share...
FlowSmart infusion set officially discontinued. On the plus side, BD plans to launch a tubeless type 2 diabetes insulin patch pump starting in late 2019.
The first GLP-1 pill for type 2 diabetes offers weight loss and A1C reduction without injections; US decision expected in September 2019, EU decision expected spring of...
The benefits of measuring time in range, plus new care guidelines for adults with type 2 diabetes
Our readers have spoken! See ten of the most popular diaTribe articles.

Pages